Increased albumin CSF/serum ratio in dementia with Lewy bodies

Journal of the Neurological Sciences

Volumn 358, Issue 1-2, 2015, Pages 398-403

  Llorens, Franc ^a,b   Schmitz, Matthias ^a,b   Gloeckner, Sara Friederike ^a   Kaerst, Lisa ^a   Hermann, Peter ^a   Schmidt, Christian ^a   Varges, Daniela ^a   Zerr, Inga ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Albumin ratio; A 42; Biomarker; Cerebrospinal fluid; Dementia; Dementia with Lewy bodies; Neurodegenerative diseases; Synucleinopathies

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN; ALBUMINOID; BIOLOGICAL MARKER; SERUM ALBUMIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID SERUM ALBUMIN RATIO; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; ENCEPHALITIS; EPILEPSY; FEMALE; HUMAN; MALE; METABOLIC RATIO; MIDDLE AGED; MULTIINFARCT DEMENTIA; NORMOTENSIVE HYDROCEPHALUS; PARKINSON DISEASE; PARKINSON DISEASE DEMENTIA; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; RECEIVER OPERATING CHARACTERISTIC; SPORADIC CREUTZFELDT JAKOB DISEASE; BLOOD; CEREBROSPINAL FLUID; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALBUMINS; BIOMARKERS; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; SERUM ALBUMIN;

EID: 84956582801     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2015.10.011     Document Type: Article

References (53)

1. M. Andersson, J. Alvarez-Cermeno, G. Bernardi, I. Cogato Fredman, J. Frederiksen, S. Fredrikson Gallo, L.M. Grimaldi, and M. Gronning Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report J. Neurol. Neurosurg. Psychiatry 57 1994 897 902
2. K. Blennow, A. Wallin Fredman, I. Karlsson, C.G. Gottfries, and L. Svennerholm Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors Acta Neurol. Scand. 81 1990 323 326
3. K. Blennow, H. Zetterberg, and A.M. Fagan Fluid biomarkers in Alzheimer disease Cold Spring Harb. Perspect. Med. 2 2012 a006221
4. B.J. Blyth, A. Farhavar, C. Gee, B. Hawthorn, H. He, A. Nayak, V. Stocklein, and J.J. Bazarian Validation of serum markers for blood-brain barrier disruption in traumatic brain injury J. Neurotrauma 26 2009 1497 1507
5. T.C. Buter, A. van den Hout, F.E. Matthews, J.P. Larsen, C. Brayne, and D. Aarsland Dementia and survival in Parkinson disease: a 12-year population study Neurology 70 2008 1017 1022
6. S. Chalbot, H. Zetterberg, K. Blennow, T. Fladby, N. Andreasen, I. Grundke-Iqbal, and K. Iqbal Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease J. Alzheimers Dis. 25 2011 505 515
7. Y.L. Chung, A. Williams, J.S. Beech, S.C. Williams, J.D. Bell, I.J. Cox, and J. Hope MRI assessment of the blood-brain barrier in a hamster model of scrapie Neurodegeneration 4 1995 203 207
8. J. Correale, A.L. Rabinowicz, C.N. Heck, T.D. Smith, W.J. Loskota, and C.M. DeGiorgio Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier Neurology 50 1998 1388 1391
9. E. Csuka, M.C. Morganti-KossmannM. Lenzlinger, H. Joller, O. Trentz, and T. Kossmann IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function J. Neuroimmunol. 101 1999 211 221
10. R.J. De, V. Deramecourt, C. Cordonnier, D. Leys, F. Pasquier, and C.A. Maurage Prevalence of cerebrovascular lesions in patients with Lewy body dementia: a neuropathological study Clin. Neurol. Neurosurg. 115 2013 1094 1097
11. J. de Vries, W.A. Thijssen, S.E. Snels, T. Menovsky, N.G. Peer, and K.J. Lamers Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients J. Neurol. Neurosurg. Psychiatry 71 2001 671 674
12. F. Deisenhammer, A. Bartos, R. Egg, N.E. Gilhus, G. Giovannoni, S. Rauer, and F. Sellebjerg Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur. J. Neurol. 13 2006 913 922
13. B. Dubois, H.H. Feldman, C. Jacova, S.T. Dekosky Barberger-Gateau, J. Cummings, A. Delacourte, D. Galasko, S. Gauthier, G. Jicha, K. Meguro, J. O'brien, F. Pasquier Robert, M. Rossor, S. Salloway, Y. SternJ. Visser, and P. Scheltens Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol. 6 2007 734 746
14. I. Elovaara, A. Icen, J. Palo, and T. Erkinjuntti CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis. J. Neurol. Sci. 70 1985 73 80
15. M. Emre, D. Aarsland, R. Brown, D.J. Burn, C. Duyckaerts, Y. Mizuno, G.A. Broe, J. Cummings, D.W. Dickson, S. Gauthier, J. Goldman, C. Goetz, A. Korczyn, A. Lees, R. Levy, I. Litvan, I. McKeith, W. Olanow, W. Poewe, N. Quinn, C. Sampaio, E. Tolosa, and B. Dubois Clinical diagnostic criteria for dementia associated with Parkinson's disease Mov. Disord. 22 2007 1689 1707
16. S.N. Gomperts, J.J. Locascio, M. Marquie, A.L. Santarlasci, D.M. Rentz, J. Maye, K.A. Johnson, and J.H. Growdon Brain amyloid and cognition in Lewy body diseases Mov. Disord. 27 2012 965 973
17. S.N. Gomperts, D.M. Rentz, E. Moran, J.A. Becker, J.J. Locascio, W.E. Klunk, C.A. Mathis, D.R. Elmaleh, T. Shoup, A.J. Fischman, B.T. Hyman, J.H. Growdon, and K.A. Johnson Imaging amyloid deposition in Lewy body diseases Neurology 71 2008 903 910
18. C.E. Ha, and N.V. Bhagavan Novel insights into the pleiotropic effects of human serum albumin in health and disease Biochim. Biophys. Acta 1830 2013 5486 5493
19. P. Hermann, C. Romero, C. Schmidt, C. Reis, and I. Zerr CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease PLoS One 9 2014 e105000
20. K.A. Jellinger Morphological substrates of mental dysfunction in Lewy body disease: an update J. Neural Transm. Suppl. 59 2000 185 212
21. S. Jesse, J. Brettschneider, S.D. Sussmuth, B.G. Landwehrmeyer, C.A. von Arnim, A.C. Ludolph, H. Tumani, and M. Otto Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases J. Neurol. 258 2011 1034 1041
22. L. Kaerst, A. Kuhlmann, D. Wedekind, K. Stoeck Lange, and I. Zerr Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysis J. Neurol. 260 2013 2722 2727
23. L. Kaerst, A. Kuhlmann, D. Wedekind, K. Stoeck Lange, and I. Zerr Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease J. Alzheimers Dis. 38 2014 63 73
24. L. Kaerst, A. Kuhlmann, D. Wedekind, K. Stoeck Lange, and I. Zerr Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease J. Alzheimers Dis. 38 2014 63 73
25. A. Karch, H. Manthey, C. Ponto Hermann, U. Heinemann, C. Schmidt, and I. Zerr Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia PLoS One 8 2013 e84405
26. T. Kossmann, V.H. Hans, H.G. Imhof, R. Stocker Grob, O. Trentz, and C. Morganti-Kossmann Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries Shock 4 1995 311 317
27. R. Liebsch, M.E. Kornhuber, D. Dietl, E.H. Grafin von, and B. Conrad Blood-CSF barrier integrity in multiple sclerosis Acta Neurol. Scand. 94 1996 404 410
28. C.F. Lippa, K. Ozawa, D.M. Mann, K. Ishii, T.W. Smith, S. Arawaka, and H. Mori Deposition of beta-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease Arch. Neurol. 56 1999 1111 1118
29. F.A. Luque, and S.L. Jaffe Cerebrospinal fluid analysis in multiple sclerosis Int. Rev. Neurobiol. 79 2007 341 356
30. D.M. Mann, S.M. Brown, F. Owen, M. Baba, and T. Iwatsubo Amyloid beta protein (A beta) deposition in dementia with Lewy bodies: predominance of A beta 42(43) and paucity of A beta 40 compared with sporadic Alzheimer's disease Neuropathol. Appl. Neurobiol. 24 1998 187 194
31. I.G. McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, L.A. Hansen, D.P. Salmon, J. Lowe, S.S. Mirra, E.J. Byrne, G. Lennox, N.P. Quinn, J.A. EdwardsonG. Ince, C. Bergeron, A. Burns, B.L. Miller, S. Lovestone, D. Collerton, E.N. Jansen, C. Ballard, R.A. de Vos, G.K. Wilcock, K.A. Jellinger, and R.H. Perry Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 47 1996 1113 1124
32. A.M. Minogue, R.S. Jones, R.J. Kelly, C.L. McDonald, T.J. Connor, and M.A. Lynch Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP/PS1 mice Neurobiol. Aging 35 2014 1442 1452
33. D. Muting, J.F. Kalk Koussouris, M.T. Motschenbacher, and A. Rausche The role of protein metabolism in 204 liver cirrhotics with and without hepatic encephalopathy. I. Clinical and general biochemical findings. Hepato-Gastroenterology 33 1986 61 65
34. E.A. Mutlu, A. Keshavarzian, and G.M. Mutlu Hyperalbuminemia and elevated transaminases associated with high-protein diet Scand. J. Gastroenterol. 41 2006 759 760
35. D. Neary, J.S. Snowden, L. Gustafson, U. Passant, D. Stuss, S. Black, M. Freedman, A. KerteszH. Robert, M. Albert, K. Boone, B.L. Miller, J. Cummings, and D.F. Benson Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1998 1546 1554
36. M. Otto, J. Wiltfang, H. Tumani, I. Zerr, M. Lantsch, J. Kornhuber, T. Weber, H.A. Kretzschmar, and S. Poser Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Neurosci. Lett. 225 1997 210 212
37. L. Parnetti Tiraboschi, A. Lanari, M. Peducci, C. Padiglioni, C. D'Amore, L. Pierguidi, N. Tambasco, A. Rossi, and P. Calabresi Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies Biol. Psychiatry 64 2008 850 855
38. V. Pisani, A. Stefani, M. Pierantozzi, S. Natoli Stanzione, D. Franciotta, and A. Pisani Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease J. Neuroinflammation 9 2012 188
39. H. Reiber Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases J. Neurol. Sci. 122 1994 189 203
40. G.A. Rosenberg, J. Prestopnik, J.C. Adair, B.N. Huisa, J. Knoefel, A. Caprihan, C. Gasparovic, J. Thompson, E.B. Erhardt, and R. Schrader Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials. J. Neurol. Neurosurg. Psychiatry 2015
41. C. Schmidt, M. Wolff, M. Weitz, T. Bartlau, C. Korth, and I. Zerr Rapidly progressive Alzheimer disease Arch. Neurol. 68 2011 1124 1130
42. K. Schmidtke, and M. Hull Neuropsychological differentiation of small vessel disease, Alzheimer's disease and mixed dementia J. Neurol. Sci. 203-204 2002 17 22
43. S. Seyfert, A. Faulstich, and P. Marx What determines the CSF concentrations of albumin and plasma-derived IgG? J. Neurol. Sci. 219 2004 31 33
44. I. Skoog, A. Wallin Fredman, C. Hesse, O. Aevarsson, I. Karlsson, C.G. Gottfries, and K. Blennow A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia Neurology 50 1998 966 971
45. K. Stoeck Sanchez-Juan, J. Gawinecka, A. Green, A. Ladogana, M. Pocchiari, R. Sanchez-Valle, E. Mitrova, T. Sklaviadis, J. Kulczycki, D. Slivarichova, A. Saiz, M. Calero, R. Knight, A. Aguzzi, J.L. Laplanche, K. Peoc'h, G. Schelzke, A. Karch, C.M. van Duijn, and I. Zerr Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years Brain 135 2012 3051 3061
46. S. Taheri, C. Gasparovic, B.N. Huisa, J.C. Adair, E. Edmonds, J. Prestopnik, M. Grossetete, N.J. Shah, J. Wills, C. Qualls, and G.A. Rosenberg Blood-brain barrier permeability abnormalities in vascular cognitive impairment Stroke 42 2011 2158 2163
47. G. Tibbling, H. Link, and S. Ohman Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand. J. Clin Lab. Investig. 37 1977 385 390
48. H. Wada Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio Intern. Med. 37 1998 509 513
49. A. Wallin, M. Sjogren, A. Edman, K. Blennow, and B. Regland Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia Eur. Neurol. 44 2000 229 235
50. N. Weiss, F. Miller, S. Cazaubon, and P.O. Couraud The blood-brain barrier in brain homeostasis and neurological diseases Biochim. Biophys. Acta 1788 2009 842 857
51. I. Zerr, K. Kallenberg, D.M. Summers, C. Romero, A. Taratuto, U. Heinemann, M. Breithaupt, D. Varges, B. Meissner, A. Ladogana, M. Schuur, S. Haik, S.J. Collins, G.H. Jansen, G.B. Stokin, J. Pimentel, E. Hewer, D. Collie Smith, H. Roberts, J.P. Brandel, C. van Duijn, M. Pocchiari, C. Begue Cras, R.G. Will, and P. Sanchez-Juan Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease Brain 132 2009 2659 2668
52. H. Zetterberg, J. Jakobsson, M. Redsater, U. Andreasson, E. Palsson, C.J. Ekman, C. Sellgren, A.G. Johansson, K. Blennow, and M. Landen Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment Psychiatry Res. 217 2014 143 146
53. H. Zetterberg, N. Mattsson, and K. Blennow Cerebrospinal fluid analysis should be considered in patients with cognitive problems Int. J. Alzheimers Dis. 2010 2010 163065